Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance

W. G. Van Gorp, P. Satz, C. Hinkin, O. Selnes, E. N. Miller, J. McArthur, B. Cohen, D. Paz, T. Nance-Sproson, A. Saah, L. Jacobson, J. S. Chmiel, J. P. Phair, J. Wesch, J. Dudley, B. Visscher, J. T. Becker

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Abstract

This study examined the relationship between actual and self-reported neuropsychological deficits, depression, and HIV-I serostatus. The subjects, who consisted of 479 individuals, 256 who were HIV seronegative (SN) and 233 who were HIV-I seropositive though still asymptomatic (ASP), were administered a standardized neuropsychological screening battery consisting of measures of attention, motor speed, psychomotor speed, verbal memory, verbal fluency, and depression. To assess subjects' subjective sense of their cognitive status, the Cognitive Failures Questionnaire (CFQ), a 25-item self-report questionnaire, was also administered. The results of MANOVA failed to reveal group differences between the SN and ASP groups on the measures of neuropsychological function. Similarly, the ASP and SN groups did not differ on the number or severity of reported cognitive failures. However, a positive correlation was found between CFQ scores and level of depression. These results do not support the hypothesis that ASP individuals are aware of cognitive decline prior to detection using standard neuropsychologic screening instruments. The data do suggest that the presence of depressed mood, independent of serostatus or actual neuropsychological impairment, is associated with increased cognitive complaints.

Original languageEnglish (US)
Pages (from-to)812-819
Number of pages8
JournalJournal of Clinical and Experimental Neuropsychology
Volume13
Issue number5
DOIs
StatePublished - 1991

Funding

This study examined the relationship between actual and self-reported neuropsychological deficits, depression, and HIV-1 serostatus. The subjects, who consisted of 479 individuals, 256 who were HIV seronegative (SN) and 233 who were HIV-1 seropositive though still asymptomatic (ASP), were administered a standardized neuropsychological screening battery consisting of measures of attention, motor speed, psychomotor speed, verbal memory, verbal fluency, and depression. To assess subjects' subjective sense of their cognitive status, the Cognitive Fail- ures Questionnaire (CFQ), a %item self-report questionnaire, was also administered. The results of MANOVA failed to reveal group differences between the SN and ASP groups on the measures of neuropsychological function. Similarly, the ASP and SN groups did not differ on the number or severity of reported cognitive * This research was supported by the National Institutes of Health contract NO1 A1 32520 and A1 72634 and Outpatient Clinical Research Center Grant 5 MOlRR0072, by the Department of Veteran's Affairs Medical Research Service in the form of a Merit Review Grant, and by American Foundation for AIDS Research Grant #RGOOO974. Requests for reprints may be sent to: Wilfred G. van Gorp, Ph.D., VA Medical Center West Los Angeles. Neuropsychology Laboratory (Bll 1). 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA.

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Clinical Psychology

Fingerprint

Dive into the research topics of 'Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance'. Together they form a unique fingerprint.

Cite this